<DOC>
	<DOCNO>NCT00842920</DOCNO>
	<brief_summary>Probands MCI high risk develop Alzheimer´s dementia ( AD ) . Simvastatin may lower production Amyloid , hallmark AD brain . The primary hypothesis study 60 mg Simvastatin significantly reduce Clinical Dementia Rating -Sum box ( CDR-SOB ) individual MCI compare MCI receive placebo 20 mg Simvastatin</brief_summary>
	<brief_title>Trial Simvastatin Amnestic Mild Cognitive Impairment ( MCI ) Patients</brief_title>
	<detailed_description>This national multicenter , double-blind , randomize placebo-controlled trial allow minimum follow-up time 24 month conversion-free patient . Randomization stratify prior use statin . The two stratum : 1 . `` no-statins '' : patient without treatment statin indication treatment ( accord guideline German Society Cardiology primary prevention cardiovascular disease ) ; patient randomly assign one 2 treatment ( 1 ) Simvastatin ( 60 mg ) one tablet/day ( 2 ) Placebo one tablet/day . 2 . `` low-statins '' : patient treat low dos Statins ; patient randomly assign one 2 treatment ( 1 ) Simvastatin ( 60 mg ) one tablet/day ( 2 ) 20 mg Simvastatin one tablet/day .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Self informant report gradually increase memory impairment least six month . 2 . Objective memory impairment 3 . Intact basic activity daily live 4 . Preserved general cognitive function , demented 5 . Absence detectable cause memory disorder 6 . Age 55 90 . 7 . Females without childbearing potential 8 . A total cholesterol ≥90 mg/dl 9 . LDLcholesterol ≥ 160 mg/dl ≤ 3 risk factor ≥ 190 mg/dl ≤ 2 risk factor include age 10 . Informed consent ( accord german medicinal product act , AMG §40 ( 1 ) 3b ) 11 . No participation clinical trial 2 month participation study 12 . Probands recruit clinical trial , able perform inform consent ; due worsen `` memory function '' course clinical trial , probands longer participate clinical trial , evidence , participant longer able give full inform consent . 1 . Hypersensitivity Simvastatin , active liver disease last increase serum transaminase unclear reason 2 . Unstable medical , neurological psychiatric disease 3 . Lack spouse close relative 4 . Use registered antidementia drug nootropic 5 . Chronic use antiinflammatory drug 6 . History stroke myocardial infarction 7 . LDLcholesterol 130160 mg/dl &gt; 3 risk factor 160190 mg/dl &gt; 2 risk factor include age . 8 . LDLcholesterol &gt; 190 mg/dl 9 . Comedication Diltiazem , Verapamil , Amiodarone , Itraconazole , Ketoconazole , Erythromycin , Clarithromycin , Telithromycin , Ciclosporin , Gemfibrozil , Nefazodone , HIVprotease inhibitor , Benzodiazepines , Tricyclic antipsychotic anticholinergic drug 10 . Comedication statins high dos ; low dos equivalent 20 mg Simvastatin allow take max . 2 year randomization</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>amnestic MCI</keyword>
</DOC>